Mitchell Rothstein
Pulmonary Disease · Jacksonville, FLNPI 1174576938
Payments from drug & device makers
Across 93 payments — averaging $2777.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$88K
- Eisai Inc.$46K
- GSK$43K
- Sanofi US Services Inc.$37K
- Verona Pharma, Inc.$31K
- Takeda Pharmaceuticals U.S.A., Inc.$13K
- plus $715 from 8 others
Across 18 payments — averaging $2965.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$51K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Food & beverage$834100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 3 | $87,854 |
| Eisai Inc. | 14 | $46,290 |
| GSK | 5 | $42,751 |
| Sanofi US Services Inc. | 18 | $37,287 |
| Verona Pharma, Inc. | 4 | $30,867 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $12,545 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| Acelrx Pharmaceuticals, Inc. | 1 | $109 |
| AstraZeneca | 1 | $103 |
| Merck | 1 | $97 |
| Sanofi-aventis U.S. LLC | 1 | $92 |
| Insmed, Inc. | 1 | $48 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$125
- TRELEGY ELLIPTA$119
- DUPIXENT$119
- DSUVIA$109
- TEZSPIRE$103
How this compares
$258,309 in reported general payments places this provider in the 90th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Jacksonville
- Charles BurgerJacksonville$5.6M
- Abubakr BajwaJacksonville$1.4M
- Jennifer FultonJacksonville$791K
- Sebastian Fernandez-BussyJacksonville$559K
- Remzi BagJacksonville$556K
- Jose Soto SotoJacksonville$549K
- Augustine LeeJacksonville$533K
- Jorge MalleaJacksonville$478K
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.